metaMe Health Receives FDA Clearance for Regulora®, the First FDA-authorized Treatment Specifically for Abdominal Pain Due to Irritable Bowel Syndrome (IBS)

metaMe Health, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for Regulora®, the first FDA-authorized treatment of any kind specifically for abdominal pain associated with irritable bowel syndrome (IBS) in adults.

Treatment of abdominal pain associated with IBS is poised for a fundamental shift in clinical practice. The COVID-19 pandemic has prevented patients from engaging in many of the activities of daily living and has led to increases in pain and psychological distress due to IBS-related symptoms (1). This has created a growing unmet medical need for self-administered behavioral therapy options to treat IBS.

Regulora provides behavioral therapy based on Gut-Directed Hypnotherapy (GDH) through a convenient smartphone app that can be used at home. GDH helps patients with their IBS symptoms by promoting healthier control of digestive tract function and delivering therapy designed to influence pain sensation (2). Until now, GDH has been provided only in-person by licensed therapists.

Read more…

CHICAGO (October 31, 2019) — metaMe Health, Inc., a Chicago-based prescription digital therapeutics company committed to the treatment of gastrointestinal (GI) conditions such as Irritable Bowel Syndrome (IBS), today announced that the first subject has enrolled in a pivotal study to evaluate the efficacy and safety of an all-digital, self-administered behavioral therapy for the treatment of adult subjects with symptomatic IBS.  This trial is a randomized, controlled, parallel-group study that will enroll subjects from across the United States.

Read more…

Chicago tech is officially on ?.

Today, we’re announcing the 50 people and companies that are heating up Chicago tech in our annual 50 on Fire list. We invite this year’s winners and their team, friends, family—and anyone that wants to network with Chicago’s startup community—to join us Nov. 14 at Moonlight Studios to celebrate the 2019 winners as we honor the individuals and companies that continue to keep Chicago on top.

So, what exactly makes a company or individual on fire? We’re looking at people and companies that have had a banner year—whether that’s new funding, recent product launches, big hires or innovative approaches to solving problems. Winners were sourced by nominations and selected by the Chicago Inno editorial team.

At the event we’ll also unveil the eight “Inno Blazer” winners, which are the top people/companies from each category as determined by a panel of judges. (You can get tickets to the event here.)

Now, without further ado, here are Chicago Inno’s 2019 50 on Fire.

Read more…

Chicago tech and startup companies raised at least $215 million in venture capital throughout the month of August, according to data compiled by Chicago Inno.

The month’s fundings were led by SpotHero, which raised $50 million, and LanzaTech, which raised $72 million.

August’s venture capital fundings were significantly up compared to July’s. Last month, Chicago tech and startup companies raised about $148 million.

Below are 13 Chicago tech and startup companies that raised money in August.

Read more…

Chicago-based metaMe Health, a startup focused on behavioral digital treatments gastrointestinal conditions, has raised $3.8 million in seed funding. LionBird Ventures led the round, which also saw contributions from Hemi Ventures and other unnamed backers.